Note*: This report requires 5-10 business days to complete.
DelveInsight’s “Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Acute Myeloid Leukemia (AML) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Acute Myeloid Leukemia (AML) from 2010-2020.Acute myeloid leukaemia (AML) are a type of cancer that affects the blood and bone marrow. AML is characterized by an overproduction of immature white blood cells, called myeloblasts or leukemic blasts. Overall, of all those with AML, around 20 out of 100 people (20%) will survive for 5 years or more after they are diagnosed. Younger people tend to do much better than older people. The reasons for poor survival in older age include the inability to tolerate intensive therapy resulting from concomitant medical illnesses and organ dysfunction, and a greater resistance to therapy as a result of preexisting. The future prognosis demands development of more effective therapies, particularly for elderly patients, would improve survival and increase disease prevalence. AML has the largest pipeline among leukemia’s due to its significant unmet need.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
• It also provides Market size of Acute Myeloid Leukemia (AML) for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
'
Table of Contents
• Acute Myeloid Leukemia (AML)
• Disease overview:
• Pathophysiology:
• Symptoms of disease:
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• United States
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Acute Myeloid Leukemia (AML) Market
• Global Epidemiology of Acute Myeloid Leukemia (AML) Forecasted to 2020
• Global Market size (2011-2014)
• Global Forecasted Market size (2015-2020)
• Global Market Size by Geography
• Market size of US (2011-2014)
• Forecasted Market size of US (2015-2020)
• Market size of Europe
• Market size of Germany (2011-2014)
• Forecasted Market size of Germany (2015-2020)
• Market size of United Kingdom (2011-2014)
• Forecasted Market size of United Kingdom (2015-2020)
• Market size of France (2011-2014)
• Forecasted Market size of France (2015-2020)
• Market size of Italy (2011-2014)
• Forecasted Market size of Italy (2015-2020)
• Market size of Spain (2011-2014)
• Forecasted Market size of Spain (2015-2020)
• Market size of Japan (2011-2014)
• Forecasted Market Size of Japan (2015-2020)
• Market size of ROW (2011-2014)
• Forecasted Market size of ROW (2015-2020)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Acute Myeloid Leukemia (AML) Drug Sales (USD Millions), (2014-2020)
• Table 6: Global Epidemiology of Acute Myeloid Leukemia (AML) (2011-2020)
• Table 7: Acute Myeloid Leukemia (AML) Global Market Size (USD Millions), (2011-2014)
• Table 8: Acute Myeloid Leukemia (AML) Global Market Size (USD Millions), (2015-2020)
• Table 9: Acute Myeloid Leukemia (AML) US Market Size (USD Millions), (2011-2014)
• Table 10: Acute Myeloid Leukemia (AML) US Market Size (USD Millions), (2015-2020)
• Table 11: Acute Myeloid Leukemia (AML) United Kingdom Market Size (USD Millions), (2011-2014)
• Table 12: Acute Myeloid Leukemia (AML) Germany Market Size (USD Millions), (2015-2020)
• Table 13: Acute Myeloid Leukemia (AML) United Kingdom Market Size (USD Millions), (2011-2014)
• Table 14: Acute Myeloid Leukemia (AML) United Kingdom Market Size (USD Millions), (2015-2020)
• Table 15: Acute Myeloid Leukemia (AML) France Market Size (USD Millions), (2011-2014)
• Table 16: Acute Myeloid Leukemia (AML) France Market Size (USD Millions), (2015-2020)
• Table 17: Acute Myeloid Leukemia (AML) Italy Market Size (USD Millions), (2011-2014)
• Table 18: Acute Myeloid Leukemia (AML) Italy Market Size (USD Millions), (2015-2020)
• Table 19: Acute Myeloid Leukemia (AML) Spain Market Size (USD Millions), (2011-2014)
• Table 20: Acute Myeloid Leukemia (AML) Spain Market Size (USD Millions), (2015-2020)
• Table 21: Acute Myeloid Leukemia (AML) Japan Market Size (USD Millions), (2011-2014)
• Table 22: Acute Myeloid Leukemia (AML) Japan Market Size (USD Millions), (2015-2020)
• Table 23: Acute Myeloid Leukemia (AML) ROW Market Size (USD Millions), (2011-2014)
• Table 24: Acute Myeloid Leukemia (AML) ROW Market Size (USD Millions), (2015-2020)
List of Figures
• Figure 1: Acute Myeloid Leukemia (AML) Drug Sales (USD Millions), (2011-2014)
• Figure 2: Global Epidemiology of Acute Myeloid Leukemia (AML) (2011-2020)
• Figure 3: Acute Myeloid Leukemia (AML) Global Market Size (USD Millions), (2011-2014)
• Figure 4: Acute Myeloid Leukemia (AML) Global Market Size (USD Millions), (2015-2020)
• Figure 5: Acute Myeloid Leukemia (AML) US Market Size (USD Millions), (2011-2014)
• Figure 6: Acute Myeloid Leukemia (AML) US Market Size (USD Millions), (2015-2020)
• Figure 7: Acute Myeloid Leukemia (AML) Germany Market Size (USD Millions), (2011-2014)
• Figure 8: Acute Myeloid Leukemia (AML) Germany Market Size (USD Millions), (2015-2020)
• Figure 9: Acute Myeloid Leukemia (AML) United Kingdom Market Size (USD Millions), (2011-2014)
• Figure 10: Acute Myeloid Leukemia (AML) United Kingdom Market Size (USD Millions), (2015-2020)
• Figure 11: Acute Myeloid Leukemia (AML) France Market Size (USD Millions), (2011-2014)
• Figure 12: Acute Myeloid Leukemia (AML) France Market Size (USD Millions), (2015-2020)
• Figure 13: Acute Myeloid Leukemia (AML) Italy Market Size (USD Millions), (2011-2014)
• Figure 14: Acute Myeloid Leukemia (AML) Italy Market Size (USD Millions), (2015-2020)
• Figure 15: Acute Myeloid Leukemia (AML) Spain Market Size (USD Millions), (2011-2014)
• Figure 16: Acute Myeloid Leukemia (AML) Spain Market Size (USD Millions), (2015-2020)
• Figure 17: Acute Myeloid Leukemia (AML) Japan Market Size (USD Millions), (2011-2014)
• Figure 18: Acute Myeloid Leukemia (AML) Japan Market Size (USD Millions), (2015-2020)
• Figure 19: Acute Myeloid Leukemia (AML) ROW Market Size (USD Millions), (2011-2014)
• Figure 20: Acute Myeloid Leukemia (AML) ROW Market Size (USD Millions), (2015-2020)
